Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$6.27 -0.01 (-0.16%)
As of: Nov 12, 2026 · 12:07 PM EST

Phathom Pharmaceuticals (PHAT) Interest & Investment Income (2019 - 2026)

Updated

Phathom Pharmaceuticals (PHAT) posted Interest & Investment Income of $1.6 million for Q3 2026, up 13.2% from $1.41 million a year earlier and up 6.0% from the prior quarter.

Analysis

Phathom Pharmaceuticals (PHAT) Interest & Investment Income (2019 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Interest & Investment Income at Phathom Pharmaceuticals was $6.05 million, down 35.3% year-over-year; for FY2025, it came in at $7.04 million, down 53.5% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 45.2% (FY2020 to FY2025).
  • In prior years, Phathom Pharmaceuticals' Interest & Investment Income was $15.16 million in FY2024 (+92.5%), $7.88 million in FY2023 (+269.4%), $2.13 million in FY2022 and $41,000 in FY2021 (-96.2%).
  • Quarterly Interest & Investment Income has run from a low of $6,000 in Q4 2021 to a high of $4.31 million in Q1 2024 over five years.
  • On a year-over-year basis, Interest & Investment Income increased in two of the last eight quarters, with an average decline of 31.1%.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2024, with growth of 941.4%; the weakest was Q4 2025, with a decline of 65.7%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $1.51 million (Q2 2026), $1.74 million (Q1 2026) and $1.2 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Phathom Pharmaceuticals 442.66 Mn -246.70 Mn 66.36 Mn 1.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.60 Mn
Jun 30, 2026 1.51 Mn
Mar 31, 2026 1.74 Mn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 1.41 Mn
Jun 30, 2025 1.79 Mn
Mar 31, 2025 2.64 Mn
Dec 31, 2024 3.51 Mn
Sep 30, 2024 3.71 Mn
Jun 30, 2024 3.62 Mn
Mar 31, 2024 4.31 Mn
Dec 31, 2023 3.35 Mn
Sep 30, 2023 2.72 Mn
Jun 30, 2023 348,000.00
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 726,000.00
Jun 30, 2022 112,000.00
Mar 31, 2022 7,000.00
Dec 31, 2021 6,000.00
API Access

Phathom Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PHAT&period=max&api_key=YOUR_API_KEY